World neglected tropical disease round-up

12 October 2008

A number of campaigns against what are termed neglected tropical diseases (Marketletters passim) appear to be gathering momentum with several initiatives involving drugmakers and international organizations. The scale of the problems facing health authorities worldwide was illustrated in a recent article in the Public Library of Science's Neglected Tropical Diseases journal, which reported that, in Latin America and the Caribbean, these conditions are the most common among 200 million of the poorest people.

Among the diseases listed in the PLoS study, there are nearly 10 million cases of Chagas disease alone, with tens of millions of intestinal worm infections. Peter Hotez, president of the USA-headquartered Sabin Vaccine Institute, who co-authored the Latin American report, said: "our findings indicate that the combined disease burden of NTDs in Latin America and the Caribbean appears to exceed that of HIV/AIDS, tuberculosis and malaria. Yet we have the proven, effective, low-cost tools at our fingertips to eliminate at least three of these devastating diseases."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight